Biological activity of bicyclic and tricyclic diterpenoids from Salvia species of immediate pharmacological and pharmaceutical interest

Natural Product Communications

Volumn 6, Issue 8, 2011, Pages 1205-1215

  Bonito, Maria Carmela ^a   Cicala, Carla ^a   Marcotullio, Maria Carla ^b   Maione, Francesco ^a   Mascolo, Nicola ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Biological activities; Diterpenoids; Lamiaceae; Natural compounds; Salvia species; Terpenoids

Indexed keywords

15,16 EPOXYCLERODA 3 EN 7ALPHA,10BETA DIHYDROXY 12,17,19,18 DIOLIDE; BICYCLIC DITERPENOID; CARNOSIC ACID; DITERPENOID; DIVINATORIN D; LINEAROLACTONE; SALVIA AFRICANA LUTEA EXTRACT; SALVIA CINNABARINA EXTRACT; SALVIA CORRUGATA EXTRACT; SALVIA DIVINORUM EXTRACT; SALVIA EXTRACT; SALVIA JAMENSIS EXTRACT; SALVIA LANIGERA EXTRACT; SALVIA MICROPHYLLA EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SALVIA PRZEWALSKII EXTRACT; SALVIA YUNNANENSIS EXTRACT; SALVILEUCALIN B; SALVINICIN A; SALVINICIN B; SALVINORIN A; SALVINORIN B; SALVINORIN C; SALVINORIN G; SALVISPLENDIN A; SALVISPLENDIN B; SALVISPLENDIN C; SALVISPLENDIN D; TRICYCLIC DITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG; BIOLOGICAL PRODUCT; DITERPENE;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; CELL AGGREGATION; CELL PROLIFERATION; CYTOTOXICITY; DIGESTIVE FUNCTION; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; GLYCEMIC CONTROL; HUMAN; IC 50; LIPOLYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REVIEW; SALVIA; SALVIA AFRICANA LUTEA; SALVIA CINNABARINA; SALVIA CORRUGATA; SALVIA DIVINORUM; SALVIA JAMENSIS; SALVIA LANIGERA; SALVIA MICROPHYLLA; SALVIA MILTIORRHIZA; SALVIA PRZEWALSKII; SALVIA YUNNANENSIS; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION;

LAMIACEAE; SALVIA; TETRA;

BIOLOGICAL PRODUCTS; DITERPENES; MOLECULAR STRUCTURE; SALVIA;

EID: 80054787142     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1100600839     Document Type: Review

References (108)

1. Kintzios SE. (2000) Sage: The Genus Salvia.(Ed). Kintzios SE. Harwood Academic Publishers, Amsterdam pp. 1-296.
2. Topçu G. (2006) Bioactive triterpenoids from Salvia species. Journal of Natural Products, 69, 482-487.
3. Capasso F, De Pasquale R, Grandolini G, Mascolo N. (2000) Farmacognosia. (Ed). Springer-Verlag Italia, Milano 1-189.
4. Habibi Z, Fereshteh E, Keivandokht S, Abdolhossein R. (2000) Structure and antibacterial activity of a new labdane diterpenoid from Salvia leriaefolia. Journal of Natural Products, 63, 270-271. (Pubitemid 30126937)
5. Rustaiyan A, Masoudi S, Tabatabaei-Anaraki M. (2007) Terpenoids from Iranian Salvia species. Natural Product Communications, 2,1031-1042.
6. Hanson JR. (2007) Diterpenoids. Natural Product Reports, 6,1332-1341.
7. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB. (2002) Salvinorin A: A potent naturally occurring non nitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences, 99, 11934-11939 (Pubitemid 34994502)
8. Chavkin C, Sud S, Jin W, Stewart J, Zjawiony J, Siebert DJ, Toth BA, Hufeisen SJ, Roth BL. (2004) Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious kappa-opioid receptor agonist: Structural and functional considerations. Journal of Pharmacology and Experimental Therapeutics, 308, 1197-1203. (Pubitemid 38263998)
9. Lee DYW, Ma Z, Liu C, Lee Y, Wang Y, Chen Y, Carlezon WA, Cohen B. (2005) New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa - opioid receptors. Bioorganic and Medicinal Chemistry, 13, 5635-5639. (Pubitemid 41187926)
10. Shirota O, Nagamatsu K, Sekita S. (2006) Neo-clerodane diterpenes from the hallucinogenic Sage Salvia divinorum. Journal of Natural Products, 69, 1782-1786. (Pubitemid 46144975)
11. Fontana G, Savona G, Rodríguez B. (2006) Clerodane diterpenoids from Salvia splendens. Journal of Natural Products, 69, 1734-1738. (Pubitemid 46144967)
12. Fontana G, Savona G, Rodríguez B, Dersch CM, Rothman RB, Prisinzano TE. (2008) Sintetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of opioid receptors affinity. Tetrahedron, 64, 10041-10048.
13. Capasso R, Borrelli F, Zjawiony JK, Kutrzeba L, Aviello G, Capasso F, Izzo AA. (2008) The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice. Neurogastroenterology Motility, 20, 142-148.
14. Capasso R, Borrelli F, Cascio MG, Aviello G, Huben K, Zjawiony JK, Marini P, Romano B, Di Marzo V, Capasso F, Izzo AA. (2008) Inibitory effect of salvinorina A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. British Journal of Pharmacology, 155, 681-689.
15. Aoyagi Y, Yamazak A, Nakatsugawa C, Fukaya H, Takeya K, Kawauchi S, Izumi H. (2008) Salvileucalin B, a novel diterpenoid with an unprecedented rearranged neoclerodane skeleton from Salvia leucantha Cav. Organic Letters, 10, 4429-4432.
16. Bisio A, Romussi G, Russo E, De Tommasi N, Mascolo N, Alfieri A, Bonito MC, Cicala C. (2008) Platelet antiaggregating activity and chemical constituents of Salvia jamensis J. Compton. Natural Product Communications, 3, 881-884.
17. Calzada F, Yepez-Mulia L, Tapia-Contreras A, Bautista E, Maldonado E, Ortega A. (2010) Evaluation of the antiprotozoal activity of Neo-clerodane type diterpenes from Salvia polystachya against Entamoeba histolytica and Giardia lamblia. Phytotherapy Research, 24, 662-665.
18. Ninomiya K, Yoshino T, Morikawa T, Yoshikawa M. (2004) Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorganic and Medicinal Chemistry Letters, 14, 1943-1946. (Pubitemid 38410869)
19. Rau O, Wurglics M, Paulke A, Zitzkowski J, Meindl N, Bock A, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M. (2006) Carnosic acid and carnosol, phenolic diterpene compounds of the labiatae herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Medica, 72, 881-887. (Pubitemid 44378949)
20. Poeckel D, Greiner C, Verhoff M, Rau O, Tausch L, Hörnig C, Steinhilber D, Schubert-Zsilavecz M, Werz O. (2008) Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes. Biochemical Pharmacology, 76, 91-97.
21. Hussein AA, Mever JJ, Jimeno ML, Rodrìguez B. (2007) Bioactive diterpenes from Orthosiphon labiatus and Salvia Africanalutea. Journal of Natural Products, 70, 293-295. (Pubitemid 46447647)
22. Horiuchi K, Shiota S, Kuroda T, Hatano T, Yoshida T, Tsuchiya T. (2007) Potentiation of antimicrobial activity of aminoglycosides by carnosol from Salvia officinalis. Biological & Pharmaceutical Bulletin, 30, 287-290.
23. Aydogmus Z, Yesilyurt V, Topçu G. (2006) Constituents of Salvia microphylla. Natural Product Research, 20, 775-781. (Pubitemid 43878613)
24. Kavvadias D, Monschein V, Sand P, Riederer P, Schreier P. (2003) Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor. Planta Medica, 69, 113-117. (Pubitemid 36384493)
25. Kuzma L, Rózalski M, Walencka E, Rózalska B, Wysokińska H. (2007) Antimicrobial activity of diterpenoids from hairy roots of Salvia sclarea L.: salvipisone as a potential anti-biofilm agent active against antibiotic resistant Staphylococci. Phytomedicine, 14, 31-35. (Pubitemid 46019787)
26. Walencka E, Rózalska S, Wysokińska H, Rózalski M, Kuźma Ł, Rózalska B.(2007) Salvipisone and aethiopinone from Salvia sclarea hairy roots modulate Staphylococcal antibiotic resistance and express anti-biofilm activity. Planta Medica, 73, 545-551. (Pubitemid 46984841)
27. Slamenová D, Masterová I, Lábaj J, Horváthová E, Kubala P, Jakubíková J, Wsólová L. (2004) Cytotoxic and DNA-damaging effects of diterpenoid quinones from the roots of Salvia officinalis L. on colonic and hepatic human cells cultured in vitro. Basic & Clinical Pharmacology & Toxicology, 94, 282-290.
28. Xu G, Peng LY, Lu L, Weng ZY, Zhao Y, Li XL, Zhao QS, Sun HD. (2006) Two new abietane diterpenoids from Salvia yunnanensis. Planta medica, 72, 84-86. (Pubitemid 43241601)
29. Chen X, Ding J, Yong-Mao Y, Zhang JS. (2002) Bioactive abietane and seco-abietane diterpenoids from Salvia prionitis. Journal of Natural Products, 65, 1016-1020 (Pubitemid 34827489)
30. Zhou L, Zuo Z, Chow MS. (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology, 45, 1345-1359. (Pubitemid 41643896)
31. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki H, Kimura I. (2008) Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacology & Therapeutics, 17, 280-295.
32. Dat NT, Xuejun J, Lee JH, Lee D, Hong YS, Lee K, Kim YH, Lee JJ. (2007) Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1. Journal of Natural Products, 70, 1093-1097. (Pubitemid 47287438)
33. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 16, 4604-4613. (Pubitemid 26272112)
34. Nizamutdinova IT, Lee GW, Son KH, Jeon SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC, Kim HJ. (2008) Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. International Journal of Oncology, 33, 485-491.
35. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Koresmeyer SJ. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 292, 727-730. (Pubitemid 32385543)
36. Nizamutdinova IT, Lee GW, Lee JS, Cho MK, Son KH, JeoKuzma L, Rózalski M, Walencka E, Rózalska B, Wysokińska Hn SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC, Kim HJ.(2008) Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis, 29, 1885-18892.
37. Lee CY, Sher HF, Chen HW, Liu CC, Chen CH, Lin CS, Yang PC, Tsay HS, Chen JJ. (2008) Anticancer effects of tanshinone I in human non-small cell lung cancer. Molecular Cancer Therapeutics, 7, 3527-3538.
38. Jeon SJ, Son KH, Kim YS, Choi YH, Kim HP. (2008) Inhibition of prostaglandin and nitric oxide production in lipopolysaccharide-treated RAW 264.7 cells by tanshinones from the roots of Salvia miltiorrhiza bunge. Archives of Pharmacal Research, 31, 758-763.
39. Jin YC, Kim CW, Kim YM, Nizamutdinova IT, Ha YM, Kim HJ, Seo HG, Son KH, Jeon SJ, Kang SS, Kim YS, Kam SC, Lee JH, Chang KC. (2009) Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. European Journal of Pharmacology, 614, 91-97.
40. Liu JJ, Lin DJ, Liu PQ, Huang M, Li XD, Huang RW. (2006) Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. Journal Biomedical Science, 13, 813-823. (Pubitemid 44900653)
41. Zhou L, Chan WK, Xu N, Xiao K, Luo H, Luo KQ, Chang DC. (2008) Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest. Life Science, 83, 394-403.
42. Liu JJ, Zhang Y, Lin DJ, Xiao RZ. (2009) Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis. Oncology Reports, 21, 1075-1081.
43. Kim HK, Woo ER, Lee HW, Park HR, Kim HN, Jung YK, Choi JY, Chae SW, Kim HR, Chae HJ. (2008) The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, criptotanshinone and diidrotanshinone. Immunopharmacology and Immonotoxicology, 30, 347-364.
44. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P. (2007) Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. European Journal of Pharmacology, 568, 213-221. (Pubitemid 46976900)
45. Li X, Du JR, Bai B, Yu Y, Zheng XY, Yang F, Zheng H. (2008) Inhibitory effects and mechanism of tanshinone IIA on proliferation of rat aortic smooth muscle cells. China Journal of Chinese Materia Medica, 33, 2146-2150.
46. Kang YJ, Jin UH, Chang HW, Son JK, Lee SH, Son KH, Chang YC, Lee YC, Kim CH. (2008) Inhibition of microsomal triglyceride transfer protein expression and atherogenic risk factor apolipoprotein B100 secretion by tanshinone IIA in HepG2 cells. Phytotherapy Research, 22, 1640-1645.
47. Jung SH, Seol HJ, Jeon SJ, Son KH, Lee JR. (2009) Insulin-sensitizing activities of tanshinones, diterpene compounds of the roots of Salvia miltiorrhiza Bunge. Phytomedicine, 16, 327-335.
48. Fang ZY, Lin R, Yuan BX, Liu Y, Zhang H. (2007) Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet. Life Sciences, 81, 1339-1345. (Pubitemid 47599531)
49. Jin UH, Suh SJ, Chang HW, Son JK, Lee SH, Son KH, Chang YC, Kim CH. (2008) Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signalling pathway. Journal of Cellular Biochemistry, 104, 15-26.
50. Wu GB, Zhou EX, Qing DX. (2009) Tanshinone II(A) elicited vasodilation in rat coronary arteriole: roles of nitric oxide and potassium channels. European Journal of Pharmacology, 617, 102-107.
51. Ren ZH, Tong YH, Xu W, Ma J, Chen Y. (2010) Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression. Phytomedicine, 17, 212-218.
52. Wan AK, Leung SW, Zhu DY, Man RY. (2008) Vascular effects of different lipophilic components of "Danshen", a traditional Chinese medicine, in the isolated porcine coronary crtery. Journal of Natural Products, 71, 1825-1828.
53. Yu C, Ye S, Sun H, Liu Y, Gao L, Shen C, Chen S, Zeng S. (2009) PXR-mediated transcriptional activation of CYP3A by cryptotanshinone and tanshinone IIA. Chemico-Biological Interactions, 177, 58-64.
54. Zhu YP. (1998) In Chinese Materia Medica: Chemistry, Pharmacology and Applications, Harwood Academic Publishers.
55. Wu B, Liu M, Zhang S. (2004) Danshen agents for acute ischaemic stroke. Cochrane Database of Systematic Review. CD004295.
56. Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Duan W, Yu XQ, Wen JY, Chowbay B, Li CG, Sheu FS, Chan E, Zhou SF. (2007) Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exhibits neuro-protective activity in experimentally stroked rats. Neuroscience Letters, 417, 261-265. (Pubitemid 46589793)
57. Yu XQ, Xue CC, Zhou ZW, Li CG, Zhou SF. (2008) Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exerts neuroprotective effect via inhibition of neuronal apoptosis in vitro. Phytotherapy Research, 22, 846-850. (Pubitemid 351955587)
58. Kim DH, Jeon SJ, Jung JW, Lee S, Yoon BH, Shin BY, Son KH, Cheong JH, Kim YS, Kang SS, Ko KH, Ryu JH. (2007) Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance tasks in mice. European Journal of Pharmacology, 574, 140-147. (Pubitemid 47592846)
59. Kim DH, Kim S, Jeon SJ, Son KH, Lee S, Yoon BH, Cheong JH, Ko KH, Ryu JH. (2009) Tanshinone I enhances learning and memory, and ameliorates memory impairment in mice via the extracellular signal-regulated kinase signalling pathway. British Journal of Pharmacology, 158, 1131-1142.
60. Mei Z, Zhang F, Tao L, Zheng W, Cao Y, Wang Z, Tang S, Le K, Chen S, Pi R, Liu P. (2009) Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Neuroscience Letters, 452, 90-95.
61. Sun CM, Chin TM, Lin YL, Chen CJ, Chen WC, Wu TS, Don MJ. (2006) Isolation, structure elucidation, and syntheses of isoneocryptotanshinone II and tanshinlactone A from Salvia miltiorrhiza. Heterocycles, 68, 247-255.
62. Wu MH, Tsai WJ, Don MJ, Chen YC, Chen IS, Kuo YC. (2007) Tanshinlactone A from Salvia miltiorrhiza modulates interleukin-2 and interferon-gamma gene expression. Journal of Ethnopharmacology, 113, 210-217. (Pubitemid 47243782)
63. El-Lakany, AM, Abdel-Kader MS, Sabri NN, Stermitz FR. (1995) Lanigerol: a new antimicrobial icetexane diterpene from Salvia lanigera. Planta Medica, 61, 559-560.
64. Fraga, BM, Díaz CE, Guadaño A, González-Coloma A. (2005) Diterpenes from Salvia broussonetii transformed roots and their insecticidal activity. Journal of Agricultural and Food Chemistry, 53, 5200-5206. (Pubitemid 40994826)
65. Simmons EM, Sarpong R. (2009) Structure, biosynthetic relationships and chemical synthesis of the icetexane diterpenoids. Natural Product Reports, 26, 1195-1217.
66. Nieto M, García EE, Giordano OS, Tonn CE. (2000) Icetexane and abietane diterpenoids from Salvia gilliessi. Phytochemistry, 53, 911-915. (Pubitemid 30233122)
67. Sanchez AM, Jimenez-Ortiz V, Sartor T, Tonn CE, García EE, Nieto M, Burgos MH, Sosa MA. (2006) A novel icetexane diterpene, 5-epi-icetexone from Salvia gilliessi is active against Trypanosoma cruzi. Acta Tropica, 98, 118-124. (Pubitemid 43783135)
68. Bisio A, Romussi G, Russo E, Cafaggi S, Schito AM, Repetto B, De Tommasi N. (2008) Antimicrobial activity of the ornamental species Salvia corrugata, a potential new crop for extractive purposes. Journal Agricultural Food Chemistry, 56, 10468-10471.
69. Giannoni P, Narcisi R, De Torero D, Romussi G, Quarto R, Bisio A. (2010) The administration of demethyl fruticulin A from Salvia corrugata to mammalian cells lines induces "anoikis", a special form of apoptosis. Phytomedicine, 17, 449-456.
70. Esquivel B, Calderon JS, Flores E, Chavez C, Juarez M. (1997) Abietane and icetaxane diterpenoids from Salvia pubescens. Natural Product Research, 10, 87-93. (Pubitemid 27292331)
71. Romussi G, Ciarallo G, Bisio A, Fontana N, De Simone F, De Tommasi N, Mascolo N, Pinto L. (2001) A new diterpenoid with antispasmodic activity from Salvia cinnabarina. Planta Medica, 67, 153-155. (Pubitemid 32234680)
72. Capasso R, Izzo AA, Capasso F, Romussi G, Bisio A, Mascolo N. (2004) A diterpenoid from Salvia cinnabarina inhibits mouse intestinal motility in vivo. Planta Medica, 70, 375-377. (Pubitemid 38594614)
73. Capasso R, Izzo AA, Romussi G, Capasso F, De Tommasi N, Bisio A, Mascolo N. (2004) A seicoisopimarane diterpenoid from Salvia cinnabarina inhibits rat urinary bladder contractility in vitro. Planta Medica, 70, 185-188. (Pubitemid 38299786)
74. Alfieri A, Maione F, Bisio A, Romussi G, Mascolo N, Cicala C. (2007) Effect of a diterpenoid from Salvia cinnabarina on arterial blood pressure in rats. Phytotherapy Research, 21, 690-692. (Pubitemid 47066787)
75. Maione F, Bonito MC, Colucci MA, Cozzolino V, Bisio A, Romussi G, Cicala C, Pieretti S, Mascolo N. (2009) First evidence for anxiolitic effect of a diterpenoid from Salvia cinnabarina. Natural Product Communications, 4, 469-472.
76. Di Sotto A, Mastrangelo S, Romussi G, Bisio A, Mazzanti G. (2009) Antimutagenic activity of a secoisopimarane diterpenoid from Salvia cinnabarina M. Martens et Galeotti in the bacterial reverse mutation assay. Food and Chemical Toxicology, 47, 2092-2096.
77. Bisio A, Fraternale D, Damonte G, Millo E, Lanteri AP, Russo E, Romussi G, Parodi B, Ricci D, De Tommasi N. (2009) Phytotoxic activity of Salvia x jamensis. Natural Product Commununications, 4, 1621-1630.
78. De Smet PA. (1997)The role of plant-derived drugs and herbal medicines in healthcare. Drugs, 54, 801-840.
79. 2 ratio alteration following myocardial ischemia-reperfusion in patients undergoing intracardiac surgery. Chinese Journal of Integrated Traditional and Western Medicine, 20, 896- 898.
80. Yu W, Shen F, Ma Z. (2000) Observation of therapeutic effect of Salvia miltiorrhiza and cytosine diphosphate-choline injection on patients with hypertensive cerebral hemorrhage. Chinese Journal of Integrated Traditional and Western Medicine, 20, 94-96.
81. Jiang FX, Wang SJ, Zhong L. (2001) Clinical observation of compound Salvia injection in treating mid-severe infantile hypoxicischemic encephalopathy. Chinese Journal of Integrated Traditional and Western Medicine, 21, 903-905.
82. Xia Z, Gu J, Ansley DM, Xia F, Yu J. (2003) Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. Journal of Thoracic and Cardiovascular Surgery, 126, 1404-1410. (Pubitemid 37449166)
83. Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A. (2007) Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care, 30, 2804-2810. (Pubitemid 350083122)
84. Zhang SJ, Cheng ZX, Lin YW, Qin J, Cheng YH, Liu SL. (2007) Effection of compositie Salvia e dropping pill on hyperlipemia patients with phlegm and blood stasis syndrome China Journal of Chinese Materia Medica, 32, 440-443.
85. Li YQ, Jin M, Qiu SL, Wang PL, Zhu TG, Wang CL, Li TC, Liu HX, Bian H, Yao LF, Shi DZ. (2009) Effect of Chinese drugs for supplementing Qi, nourishing Yin and activating blood circulation on myocardial perfusion in patients with acute myocardial infarction after revascularization. Chinese Journal of Integrated Medicine, 15, 19-25.
86. Tam WY, Chook P, Qiao M, Chan LT, Chan TY, Poon YK, Fung KP, Leung PC, Woo KS. (2009) The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients. Journal of Alternative and Complementary Medicine, 15, 415-421.
87. Xu G, Zhao W, Zhou Z, Zhang R, Zhu W, Liu X. (2009) Danshen extracts decrease blood C reactive protein and prevent ischemic stroke recurrence: a controlled pilot study. Phytotherapy Research, 23, 1721-1725.
88. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. (2003) Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics, 28, 53-59. (Pubitemid 36313176)
89. Perry NS, Bollen C, Perry EK, Ballard C. (2003) Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacology Biochemistry and Behavior, 75, 651-659. (Pubitemid 36936899)
90. Tildesley NT, Kennedy DO, Perry EK, Ballard CG, Wesnes KA, Scholey AB. (2005) Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiology & Behavior, 83, 699-709. (Pubitemid 40091602)
91. Kennedy DO, Pace S, Haskell C, Okello EJ, Milne A, Scholey AB. (2006) Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology, 31, 845-852.
92. Scholey AB, Tildesley NT, Ballard CG, Wesnes KA, Tasker A, Perry EK, Kennedy DO. (2008) An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology, 198, 127-139.
93. Peng B, Du J, Jia Q, Qiao A, Wu Y, Liu X, Qiang Q. (2001) The effect of Salvia miltiorrhiza and Shengmai on inflammatory mediator and renal function of post-operative patients with obstructive jaundice. Journal of West China University of Medical Sciences, 32, 587-589. (Pubitemid 33138933)
94. Hubbert M, Sievers H, Lehnfeld R, Kehrl WV. (2006) Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis. European Journal of Medical Research, 11, 20-26. (Pubitemid 43216407)
95. Pu C, Yang YB, Sun QL. (2006) Effects of Salvia miltiorrhiza on oxidative stress and microinflammatory state in patients undergoing continuous hemodialysis. Chinese Journal of Integrated Traditional and Western Medicine, 26, 791-794.
96. Peng GL, Zhang XY. (2007) Effects of Salvia miltiorrhiza on serum levels of inflammatory cytokines in patients with severe acute pancreatitis Journal of Chinese Integrative Medicine, 5, 28-31.
97. Schapowal A, Berger D, Klein P, Suter A. (2009) Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial. European Journal of Medical Research, 14, 406-412.
98. Sun M, Zhang JJ, Shan JZ, Zhang H, Jin CY, Xu S, Wang YL. (2009) Clinical observation of Danhong injection (herbal TCM product from Radix Salvia miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma. Phytomedicine, 16, 683-689.
99. Liang YG, Chu XJ. (2002) Effect of compound Salvia pill combined with propranolol on liver fibrosis and portal hypertension. Chinese Journal of Integrated Traditional and Western Medicine, 22, 382-383.
100. She SF, Huang XZ, Tong GD. (2004) Clinical study on treatment of liver fibrosis by different dosages of Salvia injection. Chinese Journal of Integrated Traditional and Western Medicine, 24, 17-20.
101. Ye F, Liu Y, Qiu G, Zhao Y, Liu M. (2005) Clinical study on treatment of cirrhosis by different dosages of Salvia injection. Journal of Chinese Medicinal Materials, 28, 850-854.
102. Jin CX, Yang J, Sun HF. (2006) Comparative study of the clinical effects of Salvia miltiorrhiza injection and Shengmai injection on chronic hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine, 26, 936-938.
103. Wong CK, Bao YX, Wong EL, Leung PC, Fung KP, Lam CW. (2005) Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. American Journal of Chinese Medicine, 33, 381-395. (Pubitemid 40909136)
104. Ji KT, Zhang HQ, Tang JF, Li HY. (2007) Effects of Danshen on number and activity of endothelial progenitor cells of patients with hypercholesterolemia. China Journal of Chinese Materia Medica, 32, 1214-1217.
105. Tian XH, Xue WJ, Ding XM. (2005) Application of Danshen injection on early stage of renal transplantation. Chinese Journal of Integrated Traditional and Western Medicine, 25, 404-407.
106. Han Y, Wang ZK, Wang ZD. (2004) Observation on therapeutic effect of compound Salvia drop-pill in treating vasovagal syncope. Chinese Journal of Integrated Traditional and Western Medicine, 24, 452-454.
107. Reuter J, Jocher A, Hornstein S, Mönting JS, Schempp CM. (2007) Sage extract rich in phenolic diterpenes inhibits ultraviolet-induced erythema in vivo. Planta Medica, 73, 1190-1191. (Pubitemid 47572354)
108. Yan FF, Liu YF, Liu Y, Zhao YX. (2009) Sulfotanshinone Sodium Injection could decrease fibrinogen level and improve clinical outcomes in patients with unstable angina pectoris. International Journal of Cardiology, 135, 254-255.